Amgen Inc. (NASDAQ:AMGN) Holdings Trimmed by Cypress Capital Group

Adjust Comment Print

Therefore 20% are positive. Amgen Inc. has a 12 month low of $133.64 and a 12 month high of $176.85. They set a "buy" rating and a $164.00 price target on the stock. Jackson Grant Investment Advisers Inc. raised its position in shares of Amgen by 0.6% during the first quarter. (NASDAQ:AMGN) on Wednesday, May 24. Oppenheimer maintained it with "Buy" rating and $203.0 target in Wednesday, August 23 report. (NASDAQ:AMGN) rating on Friday, July 31. They set a "sector perform" rating and a $192.00 target price for the company. On Friday, December 18 the stock rating was initiated by Atlantic Securities with "Overweight". On Monday, December 14 the stock rating was initiated by Ladenburg Thalmann with "Buy". Piper Jaffray maintained it with "Overweight" rating and $200 target in Saturday, August 29 report. Metropolitan Life Insurance Company New York stated it has 0.42% in Amgen, Inc. (NASDAQ:AMGN) has "Buy" rating given on Wednesday, August 16 by Oppenheimer. Twin Tree Mgmt Ltd Partnership invested 0.06% of its portfolio in Amgen, Inc. As per Sunday, August 27, the company rating was maintained by Jefferies. Oppenheimer has "Buy" rating and $20300 target. The firm has "Buy" rating given on Wednesday, February 1 by Bank of America. The Adelante Capital Management Llc holds 1.87M shares with $98.84 million value, down from 2.26M last quarter. Morningstar Investment Services LLC now owns 497,503 shares of the medical research company's stock valued at $81,625,000 after buying an additional 367,894 shares during the period. Middleton & Co Inc MA now owns 1,780 shares of the medical research company's stock worth $292,000 after purchasing an additional 40 shares during the period. Brown Brothers Harriman & invested in 12,449 shares. Conservest Capital Advisors Inc. raised its position in shares of Amgen by 0.4% during the second quarter. Days to cover increased 0.4 to 3.0 and the percentage of shorted shares is 0.01% as of August 15. It has outperformed by 12.14% the S&P500.

Since May 24, 2017, it had 0 insider purchases, and 2 insider sales for $1.02 million activity.

Analysts await Amgen, Inc. The medical research company reported $3.27 EPS for the quarter, topping the consensus estimate of $3.11 by $0.16. LPSN's profit will be $1.18 million for 170.00 P/E if the $0.02 EPS becomes a reality. After $3.42 actual EPS reported by Aetna Inc for the previous quarter, Wall Street now forecasts -39.18% negative EPS growth. About 5.35M shares traded or 126.69% up from the average.

Amgen (NASDAQ:AMGN) last released its earnings results on Thursday, February 2nd. It has underperformed by 11.43% the S&P500. Blackrock Advsr Ltd Company invested 0.37% in Amgen, Inc. The institutional investor owned 58,688 shares of the medical research company's stock after selling 315 shares during the period. The Firm discovers, develops, makes and delivers various human therapeutics. The Commercial Real Estate Debt Investments segment includes the Company's activities and activities related to commercial real estate loans, commercial real estate-related securities and investments in real estate.

Analysts await Amgen, Inc. (NASDAQ:AMGN) for 25.00 million shares. Credit Agricole S A holds 1.09M shares. ENV's profit will be $10.99 million for 47.10 P/E if the $0.25 EPS becomes a reality. After $3.27 actual EPS reported by Amgen, Inc. for the previous quarter, Wall Street now forecasts -6.12% negative EPS growth.

Trump's bipartisan tax reform push would blow up Republicans' strategy
So far, the White House and GOP negotiators have areas of overlap but also areas of disagreement in their tax cut approach. A key topic of discussion is Trump's push for Congress to send him a bill to cut taxes for corporations and individuals.


Investors sentiment decreased to 0.69 in Q4 2016. Its down 0.10, from 1.25 in 2016Q3. About 5.35 million shares traded or 126.69% up from the average. 111 funds opened positions while 527 raised stakes. 306.97 million shares or 0.42% more from 305.68 million shares in 2016Q3 were reported.

Cantab Capital Partners Llp augmented its holdings by buying 2,601 shares an increase of 35.4% from 03/31/2017 to 06/30/2017. Cohen Klingenstein Limited Liability Com invested in 0.82% or 33,020 shares. Williams Jones And Assoc Limited Liability Corporation invested in 0.28% or 67,397 shares. Finally, Buckingham Asset Management LLC grew its stake in shares of Amgen by 4.5% during the first quarter. Folger Nolan Fleming Douglas owns 0.13% invested in Amgen, Inc.

Shoker Investment Counsel Inc increased its stake in Amgen Inc (AMGN) by 77.08% based on its latest 2016Q4 regulatory filing with the SEC. (NASDAQ:AMGN). Concorde Asset Management Ltd Company holds 1,940 shares or 0.52% of its portfolio. L & S Advsr invested in 0.05% or 1,427 shares. Murphy Management reported 0.25% in Amgen, Inc. (NASDAQ:AMGN). Westpac holds 0% of its portfolio in Amgen, Inc. (NASDAQ:AMGN). Chesley Taft & Associate Ltd Limited Liability Company holds 59,087 shares. Cantab Capital Partners Llp now owns 9,944 shares valued at $1,713,000,000. Aperio has invested 0.35% of its portfolio in Amgen, Inc. Primecap Mgmt Ca has invested 3.6% in Amgen, Inc.

A number of other institutional investors and hedge funds have also recently modified their holdings of AMGN.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Comments